Andrew Mullen, Charco Neurotech - CUE1+: A Device for Parkinson's | LSI USA '25

Charco Neurotech is dedicated to improving the quality of life for individuals with Parkinson's disease through its cutting-edge wearable technology, the CUE1 device, which aims to alleviate motor symptoms and enhance patient mobility.
Speakers
Andrew Mullen
Andrew Mullen
Chief Operating Officer, Charco Neurotech